Language selection


Backgrounder – Government of Canada investments in biomanufacturing, development of COVID-19 vaccines and therapeutics, and research

The Government of Canada's number one priority is to protect the health of Canadians. That's why the government is implementing a multi-faceted procurement strategy to provide a COVID-19 vaccine to every Canadian who wants one by September.

The government established the Vaccine and Therapeutics task forces and Biomanufacturing Subcommittee, made up of leading industry experts and scientists, to advise the government on how to address this challenge as a national priority.

Since the outset of the pandemic, the government has made a series of investments in biomanufacturing, developing domestic vaccine and therapeutic candidates, and targeted research which will help advance medical counter measures to protect Canadians, and which will also improve Canada's global competitiveness.

The government continues to take action based on the best available science, both in pursuing vaccine and therapeutic candidates and investing in biomanufacturing opportunities to fight the current pandemic, and to build resilience for future pandemics.

Funding committed through the Strategic Innovation Fund

$192 million for coronavirus research and medical countermeasures from the government's Plan to Mobilize Science (March 23, 2020).

$600 million to support COVID-19 vaccine and therapy clinical trials led by the private sector, and for Canadian bio-manufacturing opportunities. This announcement was part of the $1 billion Plan to Mobilize Science (April 23, 2020).

Funding committed through the Next Generation Manufacturing Canada Supercluster

Funding committed through the National Research Council

Funding committed through Regional Development Agencies

Funding committed through the Canada Foundation for Innovation

Funding committed through the Canadian Institutes of Health Research (CIHR), Natural Sciences and Engineering Research Council (NSERC) and Social Sciences and Humanities Research Council (SSHRC)

The Government of Canada also invested:

Variants of Concern (VOC) Research

Other investments and projects underway

For additional information, please contact:

Media Relations
Innovation, Science and Economic Development Canada

Date modified: